RAC 1.32% $1.50 race oncology ltd

Ann: Race Strategic Update August 2023, page-388

  1. 18,887 Posts.
    lightbulb Created with Sketch. 5575
    It has been a terrible couple of days and unsurprisingly my research has been on hold - I don't really feel up to it at the moment. Life is certainly not fair.

    I would like to add that I very much believe in bisantrene and these last few days have really driven home what this is all about. Bisantrene has the potential to help millions of people via the cardioprotection opportunity and has the ability to open up whole new way of treating cancer via FTO and m6A RNA. Race the company will have its ups and downs, but we should not lose focus on what really matters - helping people beat this horrible disease and live long and healthy lives afterward.

    I have not sold a single share.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.50
Change
-0.020(1.32%)
Mkt cap ! $252.5M
Open High Low Value Volume
$1.55 $1.57 $1.47 $193.8K 128.1K

Buyers (Bids)

No. Vol. Price($)
1 3000 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.51 2917 2
View Market Depth
Last trade - 15.51pm 22/05/2024 (20 minute delay) ?
Last
$1.50
  Change
-0.020 ( 0.66 %)
Open High Low Volume
$1.53 $1.56 $1.47 18229
Last updated 15.53pm 22/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.